These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 29361803)
1. Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9. Schulz H; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U; Schmoeckel E Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361803 [TBL] [Abstract][Full Text] [Related]
2. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients. Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of galectin-7 in epithelial ovarian cancer. Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797 [TBL] [Abstract][Full Text] [Related]
4. Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers. Labrie M; De Araujo LOF; Communal L; Mes-Masson AM; St-Pierre Y Sci Rep; 2017 Oct; 7(1):13244. PubMed ID: 29038585 [TBL] [Abstract][Full Text] [Related]
5. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets. Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916 [TBL] [Abstract][Full Text] [Related]
6. Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma. Liu Y; Xu L; Zhu Y; Zhang W; Liu W; Liu H; Xu J Urol Oncol; 2015 Mar; 33(3):112.e1-8. PubMed ID: 25499921 [TBL] [Abstract][Full Text] [Related]
7. Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer. Beyer S; Wehrmann M; Meister S; Trillsch F; Ganster F; Schmoeckel E; Corradini S; Mahner S; Jeschke U; Kessler M; Burges A; Kolben T Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000016 [TBL] [Abstract][Full Text] [Related]
8. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma. Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202 [TBL] [Abstract][Full Text] [Related]
9. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery. Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274 [TBL] [Abstract][Full Text] [Related]
10. Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer. Schulkens IA; Heusschen R; van den Boogaart V; van Suylen RJ; Dingemans AM; Griffioen AW; Thijssen VL PLoS One; 2014; 9(9):e107988. PubMed ID: 25259711 [TBL] [Abstract][Full Text] [Related]
11. The expression profiles of the galectin gene family in colorectal adenocarcinomas. Gopalan V; Saremi N; Sullivan E; Kabir S; Lu CT; Salajegheh A; Leung M; Smith RA; Lam AK Hum Pathol; 2016 Jul; 53():105-13. PubMed ID: 27001434 [TBL] [Abstract][Full Text] [Related]
12. Galectin-8 and -9 as prognostic factors for cervical cancer. Beyer S; Wehrmann M; Meister S; Kolben TM; Trillsch F; Burges A; Czogalla B; Schmoeckel E; Mahner S; Jeschke U; Kolben T Arch Gynecol Obstet; 2022 Oct; 306(4):1211-1220. PubMed ID: 35377045 [TBL] [Abstract][Full Text] [Related]
14. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis. Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523 [TBL] [Abstract][Full Text] [Related]
15. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Langbein S; Brade J; Badawi JK; Hatzinger M; Kaltner H; Lensch M; Specht K; André S; Brinck U; Alken P; Gabius HJ Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590 [TBL] [Abstract][Full Text] [Related]
16. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer. Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813 [TBL] [Abstract][Full Text] [Related]
18. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer. Yang J; Zhu L; Cai Y; Suo J; Jin J Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464 [TBL] [Abstract][Full Text] [Related]
19. Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease. Strohl A; Mori K; Akers S; Bshara W; Buttin B; Frederick PJ; Helenowski IB; Morrison CD; Odunsi K; Schink JC; Scholtens DM; Wei JJ; Kim JJ J Ovarian Res; 2016 Nov; 9(1):75. PubMed ID: 27809878 [TBL] [Abstract][Full Text] [Related]
20. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis. Liu H; Dai Q; Li Y; Tang Z; She T Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]